{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:56:52Z","timestamp":1790647012175,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"name":"Horizon Therapeutics USA, Inc. Global","award":["DOPPS Programs"],"award-info":[{"award-number":["DOPPS Programs"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2023,1]]},"abstract":"\n Key Points<\/jats:title>\n \n \n \n Gout is a common inflammatory arthropathy, and it can be as frequent in patients with ESKD as in the general adult population.<\/jats:p>\n <\/jats:list-item>\n \n Patient outcomes and providers' practice patterns for ESKD patients with gout are unknown. We sought to address these gaps in this study.<\/jats:p>\n <\/jats:list-item>\n \n We found that gout is not associated with worse clinical or patient-reported outcomes, despite being frequent and possibly under-reported.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:sec>\n \n Introduction<\/jats:title>\n Gout occurs frequently in patients with kidney disease and can lead to a significant burden on quality of life. Gout prevalence, and its association with outcomes in hemodialysis (HD) and peritoneal dialysis (PD) populations located in North America, is unknown.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n We used data from North America cohorts of 70,297 HD patients (DOPPS, 2012\u20132020) and 5117 PD patients (PDOPPS, 2014\u20132020). We used three definitions of gout for this analysis: (\n 1<\/jats:italic>\n ) having an active prescription for colchicine or febuxostat; (\n 2<\/jats:italic>\n ) having an active prescription for colchicine, febuxostat, or allopurinol; or (\n 3<\/jats:italic>\n ) having an active prescription for colchicine, febuxostat, or allopurinol, or prior diagnosis of gout. Propensity score matching was used to compare outcomes among patients with versus without gout. Outcomes included erythropoietin resistance index (ERI=erythropoiesis stimulating agent dose per week\/(hemoglobin\u00d7weight)), all-cause mortality, hospitalization, and patient-reported outcomes (PROs).\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The gout prevalence was 13% in HD and 21% in PD; it was highest among incident dialysis patients. Description of previous history of gout was rare, and identification of gout defined by colchicine (2%\u20133%) or febuxostat (1%) prescription was less frequent than by allopurinol (9%\u201312%). Both HD and PD patients with gout (versus no gout) were older, were more likely male, had higher body mass index, and had higher prevalence of cardiovascular comorbidities. About half of patients with a gout history were prescribed urate-lowering therapy. After propensity score matching, mean ERI was 3%\u20136% higher for gout versus non-gout patients while there was minimal evidence of association with clinical outcomes or PROs.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n In a large cohort of PD and HD patients in North America, we found that gout occurs frequently and is likely under-reported. Gout was not associated with adverse clinical or PROs.<\/jats:p>\n <\/jats:sec>","DOI":"10.34067\/kid.0005392022","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:40:15Z","timestamp":1670254815000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Gout Prevalence, Practice Patterns, and Associations with Outcomes in North American Dialysis Patients"],"prefix":"10.34067","volume":"4","author":[{"given":"Murilo","family":"Guedes","sequence":"first","affiliation":[{"name":"School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"LaMoreaux","sequence":"additional","affiliation":[{"name":"Horizon Therapeutics, Deerfield, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Marder","sequence":"additional","affiliation":[{"name":"Horizon Therapeutics, Deerfield, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Gorlitsky","sequence":"additional","affiliation":[{"name":"Carolina Nephrology, PA, Greenville, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius","family":"Domingues","sequence":"additional","affiliation":[{"name":"Florida State University, Tallahassee, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Rivara","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie","family":"Lew","sequence":"additional","affiliation":[{"name":"Division of Renal Diseases and Hypertension, Department of Medicine, George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Robinson","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health, Ann Arbor, Michigan"},{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pecoits-Filho","sequence":"additional","affiliation":[{"name":"School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil"},{"name":"Arbor Research Collaborative for Health, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Karaboyas","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the DOPPS7 Country Investigators*","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"issue":"9","key":"B1-20250823","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2007.081604","article-title":"Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans","volume":"67","author":"Singh","year":"2007","journal-title":"Ann Rheum Dis."},{"issue":"11","key":"B2-20250823","doi-asserted-by":"crossref","first-page":"e50046","DOI":"10.1371\/journal.pone.0050046","article-title":"Reduced glomerular function and prevalence of gout: NHANES 2009-10","volume":"7","author":"Krishnan","year":"2012","journal-title":"PLoS One."},{"issue":"4","key":"B3-20250823","doi-asserted-by":"crossref","first-page":"F1134","DOI":"10.1152\/ajprenal.00104.2008","article-title":"Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia","volume":"295","author":"S\u00e1nchez-Lozada","year":"2008","journal-title":"Am J Physiol Renal Physiol."},{"issue":"6","key":"B4-20250823","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.numecd.2007.02.011","article-title":"Uric acid and oxidative stress: relative impact on cardiovascular risk?","volume":"17","author":"Strazzullo","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis."},{"issue":"1","key":"B5-20250823","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1038\/s41598-019-43241-3","article-title":"Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study","volume":"9","author":"Oh","year":"2019","journal-title":"Sci Rep."},{"issue":"1","key":"B6-20250823","doi-asserted-by":"crossref","first-page":"17585","DOI":"10.1038\/s41598-020-74747-w","article-title":"Association between mortality and serum uric acid levels in non-diabetes-related chronic kidney disease: an analysis of the National Health and Nutrition Examination Survey, USA, 1999-2010","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep."},{"issue":"4","key":"B7-20250823","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00380-013-0396-0","article-title":"Serum uric acid levels and long-term outcomes in chronic kidney disease","volume":"29","author":"Miyaoka","year":"2014","journal-title":"Heart Vessels."},{"issue":"7","key":"B8-20250823","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1080\/15257770.2021.1934482","article-title":"Urate levels and clearance in renal patients under peritoneal dialysis","volume":"40","author":"Diez-Lopez","year":"2021","journal-title":"Nucleosides Nucleotides Nucleic Acids."},{"issue":"11","key":"B9-20250823","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1681\/ASN.2007111256","article-title":"Association of incident gout and mortality in dialysis patients","volume":"19","author":"Cohen","year":"2008","journal-title":"J Am Soc Nephrol."},{"issue":"5 suppl 2","key":"B10-20250823","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0272-6386(04)01099-6","article-title":"The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology","volume":"44","author":"Pisoni","year":"2004","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B11-20250823","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3747\/pdi.2014.00288","article-title":"The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): unifying efforts to inform practice and improve global outcomes in peritoneal dialysis","volume":"36","author":"Perl","year":"2016","journal-title":"Perit Dial Int."},{"issue":"3","key":"B12-20250823","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.xkme.2020.01.007","article-title":"Inflammation and erythropoiesis-stimulating agent response in hemodialysis patients: a self-matched longitudinal study of anemia management in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"2","author":"Karaboyas","year":"2020","journal-title":"Kidney Med."},{"issue":"4","key":"B13-20250823","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.ajkd.2017.07.020","article-title":"Psychometric properties of the Kidney Disease Quality of Life 36-Item Short-Form Survey (KDQOL-36) in the United States","volume":"71","author":"Peipert","year":"2018","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"B14-20250823","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00451725","article-title":"Development of the Kidney Disease Quality of Life (KDQOLTM) Instrument","volume":"3","author":"Hays","year":"1994","journal-title":"Qual Life Res."},{"issue":"12","key":"B15-20250823","doi-asserted-by":"crossref","first-page":"e634","DOI":"10.1097\/TXD.0000000000001081","article-title":"New-onset gout as an independent risk factor for returning to dialysis after kidney transplantation","volume":"6","author":"Li","year":"2020","journal-title":"Transplant Direct."},{"issue":"2","key":"B16-20250823","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0749-3797(18)30622-6","article-title":"Screening for depression in well older adults: evaluation of a Short Form of the CES-D","volume":"10","author":"Andresen","year":"1994","journal-title":"Am J Prev Med."},{"issue":"2","key":"B17-20250823","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/089826439300500202","article-title":"Two shorter forms of the CES-D depression symptoms index","volume":"5","author":"Kohout","year":"1993","journal-title":"J Aging Health."},{"issue":"3 pt 1","key":"B18-20250823","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist."},{"issue":"2","key":"B19-20250823","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.ajkd.2015.09.024","article-title":"Functional dependence and mortality in the international Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"67","author":"Jassal","year":"2016","journal-title":"Am J Kidney Dis."},{"issue":"4","key":"B20-20250823","first-page":"A118","article-title":"The Rapid Assessment of Physical Activity (RAPA) among older adults","volume":"3","author":"Topolski","year":"2006","journal-title":"Prev Chronic Dis."},{"issue":"7","key":"B21-20250823","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/imj.14163","article-title":"Serum urate levels and therapy in adults treated with long-term dialysis: a retrospective cross-sectional study","volume":"49","author":"Yeo","year":"2019","journal-title":"Intern Med J."},{"issue":"4","key":"B22-20250823","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ndt\/gfu352","article-title":"Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study","volume":"30","author":"Jing","year":"2015","journal-title":"Nephrol Dial Transplant."},{"issue":"10","key":"B23-20250823","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11926-016-0613-9","article-title":"Gout and osteoarthritis: associations, pathophysiology, and therapeutic implications","volume":"18","author":"Yokose","year":"2016","journal-title":"Curr Rheumatol Rep."},{"issue":"4","key":"B24-20250823","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1053\/j.ajkd.2022.01.052","article-title":"Risk factors and outcomes of gout in dialysis patients from the United States Renal Data System (USRDS)","volume":"79","author":"Bleyer","year":"2022","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B25-20250823","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2017.01.055","article-title":"Management of gout and hyperuricemia in CKD","volume":"70","author":"Vargas-Santos","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"26","key":"B26-20250823","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","article-title":"Effects of allopurinol on the progression of chronic kidney disease","volume":"382","author":"Badve","year":"2020","journal-title":"N Engl J Med."},{"issue":"7","key":"B27-20250823","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol."},{"issue":"11","key":"B28-20250823","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/annrheumdis-2012-201687","article-title":"Gout: why is this curable disease so seldom cured?","volume":"71","author":"Doherty","year":"2012","journal-title":"Ann Rheum Dis."},{"issue":"5","key":"B29-20250823","first-page":"679","article-title":"Drug-induced hyperuricaemia and gout","volume":"56","author":"Ben Salem","year":"2017","journal-title":"Rheumatology."},{"key":"B30-20250823","doi-asserted-by":"crossref","first-page":"d8190","DOI":"10.1136\/bmj.d8190","article-title":"Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study","volume":"344","author":"Choi","year":"2012","journal-title":"BMJ."},{"issue":"1","key":"B31-20250823","doi-asserted-by":"crossref","first-page":"19582","DOI":"10.1038\/s41598-019-55561-5","article-title":"Effectiveness of renin-angiotensin-aldosterone system blockade on residual kidney function and peritoneal membrane function in peritoneal dialysis patients: a network meta-analysis","volume":"9","author":"Phatthanasobhon","year":"2019","journal-title":"Sci Rep."},{"issue":"6","key":"B32-20250823","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology guideline for the management of gout","volume":"72","author":"Fitzgerald","year":"2020","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"10","key":"B33-20250823","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.2215\/CJN.00670111","article-title":"Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population","volume":"6","author":"Latif","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B34-20250823","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41584-019-0334-3","article-title":"Asymptomatic hyperuricaemia: a silent activator of the innate immune system","volume":"16","author":"Joosten","year":"2020","journal-title":"Nat Rev Rheumatol."},{"issue":"11","key":"B35-20250823","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/rheumatology\/kes204","article-title":"Risk factors for pseudogout in the general population","volume":"51","author":"Rho","year":"2012","journal-title":"Rheumatology (Oxford)."},{"issue":"1","key":"B36-20250823","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1471-2458-13-251","article-title":"Comparison of the information provided by electronic health records data and a population health survey to estimate prevalence of selected health conditions and multimorbidity","volume":"13","author":"Viol\u00e1n","year":"2013","journal-title":"BMC Public Health."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0005392022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:57:59Z","timestamp":1786478279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0005392022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0005392022","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"2022-08-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}